Latest California Healthline Stories
KFF Health News' 'What the Health?': Here Come the ACA Premium Hikes
Medicaid may have monopolized Washington’s attention lately, but big changes are coming to the Affordable Care Act as well. Meanwhile, Americans are learning more about what’s in Trump’s big budget law, and polls suggest many don’t like what they see. Julie Appleby of KFF Health News, Jessie Hellmann of CQ Roll Call, and Alice Miranda Ollstein of Politico join KFF Health News’ Julie Rovner to discuss these stories and more. Also this week, Rovner interviews historian Jonathan Oberlander to mark Medicare’s 60th anniversary.
KFF Health News' 'What the Health?': The Senate Saves PEPFAR Funding — For Now
The Senate narrowly approved the Trump administration’s request to claw back about $9 billion for foreign aid and public broadcasting but refused to cut funding for the international AIDS/HIV program PEPFAR. Meanwhile, a federal appeals court ruled that West Virginia can ban the abortion pill mifepristone, which could allow states to block other FDA-approved drugs. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico Magazine, Shefali Luthra of The 19th, and Sandhya Raman of CQ Roll Call join KFF Health News’ Julie Rovner to discuss these stories and more.
What RFK Jr. Isn’t Talking About: How To Make Vaccines Safer
Vaccines are under fire from the top of the Trump administration. Federal programs to monitor them and make them safer have always been underfunded.
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
A new drug is helping families who’ve spent years padlocking fridges, chaining garbage cans, and hiding food as their children with Prader-Willi syndrome deal with unrelenting hunger. But additional progress — and a broader understanding of obesity — is now under threat as the government dismantles the pipeline for promising new research.
Two Patients Faced Chemo. The One Who Survived Demanded a Test To See if It Was Safe.
Worried that President Donald Trump’s FDA might not act, a panel of cancer experts recommended that doctors consider testing before dosing patients with a commonly used but sometimes deadly cancer drug. It came too late for many patients.
Silence on E. Coli Outbreak Highlights How Trump Team’s Changes Undermine Food Safety
Food safety inspections are being scaled back and the public was not notified after an investigation into E. coli contamination.
En lo que expertos califican como un cambio radical de las prácticas habituales, las autoridades nunca emitieron comunicados públicos luego de la investigación.
KFF Health News' 'What the Health?': Bill With Billions in Health Program Cuts Passes House
The House narrowly passed a budget reconciliation bill, including billions of dollars in tax cuts for the wealthy along with billions of dollars in cuts to health program spending. But the Senate is expected to make major changes to the measure before it can go to President Donald Trump for his signature. This week’s panelists are Julie Rovner of KFF Health News, Anna Edney of Bloomberg News, Sarah Karlin-Smith of the Pink Sheet, and Alice Miranda Ollstein of Politico.
Trump’s Team Cited Safety in Limiting Covid Shots. Patients, Health Advocates See More Risk.
The FDA will encourage new clinical trials on the widely used vaccines before approving them for children and healthy adults. The requirements could cost drugmakers tens of millions of dollars and are likely to leave boosters largely out of reach for hundreds of millions of Americans this fall.
This News Might Ruin Your Appetite — And Summer
Fresh studies expose a gap in the FDA’s assessments of foods: Widely used additives could damage the mix of bacteria in your gut, causing health problems.